Cargando…
Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications
BACKGROUND: Sequencing analysis of circulating tumor cells (CTCs) enables “liquid biopsy” to guide precision oncology strategies. However, this requires low-template whole genome amplification (WGA) that is prone to errors and biases from uneven amplifications. Currently, quality control (QC) method...
Autores principales: | Sho, Shonan, Court, Colin M., Winograd, Paul, Lee, Sangjun, Hou, Shuang, Graeber, Thomas G., Tseng, Hsian-Rong, Tomlinson, James S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493892/ https://www.ncbi.nlm.nih.gov/pubmed/28666423 http://dx.doi.org/10.1186/s12885-017-3447-6 |
Ejemplares similares
-
Digital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens
por: Sho, Shonan, et al.
Publicado: (2017) -
Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells
por: Court, Colin M., et al.
Publicado: (2020) -
Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors
por: Winograd, Paul, et al.
Publicado: (2020) -
Precision oncology: as much expectations as limitations
por: Vasconcellos, Vitor Fiorin, et al.
Publicado: (2018) -
Impact of whole genome amplification on analysis of copy number variants
por: Pugh, T. J., et al.
Publicado: (2008)